Skip to main content

Peer Review reports

From: Management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a retrospective multi-institutional analysis

Original Submission
28 Sep 2019 Submitted Original manuscript
3 Feb 2020 Author responded Author comments - yuemei sun
4 Jan 2020 Reviewed Reviewer Report - Puja Gaur Khaitan
15 Jan 2020 Reviewed Reviewer Report - Mohammad Ahmad al-Shatouri
Resubmission - Version 2
3 Feb 2020 Submitted Manuscript version 2
27 Mar 2020 Author responded Author comments - yuemei sun
15 Mar 2020 Reviewed Reviewer Report - Puja Gaur Khaitan
17 Mar 2020 Reviewed Reviewer Report - Mohammad Ahmad al-Shatouri
Resubmission - Version 3
27 Mar 2020 Submitted Manuscript version 3
4 May 2020 Author responded Author comments - yuemei sun
20 Apr 2020 Reviewed Reviewer Report - Puja Gaur Khaitan
12 Apr 2020 Reviewed Reviewer Report - Mohammad Ahmad al-Shatouri
Resubmission - Version 4
4 May 2020 Submitted Manuscript version 4
10 Jun 2020 Author responded Author comments - yuemei sun
24 May 2020 Reviewed Reviewer Report - Puja Gaur Khaitan
13 May 2020 Reviewed Reviewer Report - Mohammad Ahmad al-Shatouri
Resubmission - Version 5
10 Jun 2020 Submitted Manuscript version 5
Publishing
30 Jun 2020 Editorially accepted
13 Jul 2020 Article published 10.1186/s12885-020-07122-7

You can find further information about peer review here.

Back to article page